Abstract
1. The aims of the present study were (a) to determine the identity of the G proteins with which the endothelin receptor interacts and whether this interaction is subtype specific and (b) to determine whether agonist exposure can result in specific coupling between the endothelin receptor and G proteins.
2. Coupling between endothelin A (ETA) or endothelin B (ETB) receptors and G proteins was assessed in two fibroblast cell lines, each expressing one receptor subtype. Four ligands, ET-1, ET-3, SRTXb, and SRTXc, were used for receptor stimulation. The G protein α-subunit coupled to the receptor was identified by immunoprecipitation with an antibody against the endothelin receptor and immunoblotting with specific antibodies against different G protein α-subunits.
3. Unstimulated ETA and ETB receptors (ETAR and ETBR, respectively) were barely coupled to Goα. The unstimulated ETAR coimmunoprecipitated with Gi3α, whereas the unstimulated ETBR was much less strongly coupled to Gi3α. The coupling of ETBR to Gi1Gi2 α-subunits was much stronger than the coupling of ETAR to these α-subunits. Stimulation with the different ET agonists also resulted in differential coupling of G proteins to the receptor subtypes. All four ligands caused a strong increase in coupling of the ETBR to Gi3α, whereas coupling of the ETAR to this subunit was not affected by ET-1 and was even decreased by SRTXc. On the other hand, all four ligands caused a much greater increase in the coupling of ETAR to Gqα/G11α than in the coupling of ETBR to these α-subunits. Ligand-induced coupling between the receptors and the Gi1 and Gi2 α-subunits is similar for the two receptor subtypes. The same was true for ligand-induced coupling of the receptors to Goα, except that ET-3 increased the coupling of this α-subunit to ETBR and decreased the coupling to ETAR. Taken together, the results of this study show that coupling between ET receptors and G proteins is ligand and receptor subtype specific.
4. It remains to be established whether this diversity of receptor–G protein coupling is of relevance for the various endothelin signaling pathways and/or pathological states.
Similar content being viewed by others
REFERENCES
Ambar, I., and Sokolovsky, M. (1993). Eur. J. Pharmacol. 245:31-41.
Aquilla, E., Whelchel, A., Knot, H. J., Nelson, M., and Posada, J. (1996). J. Biol. Chem. 271:31572-31579.
Aramori, I., and Nakanishi, S. (1992). J. Biol. Chem. 267:12468-12474; J. Biol. Chem. 270:10072-10078.
Diverse-Pierluissu, M., Remmers, A. E., Neubig, R. R., and Dunlap, K. (1997). Proc. Natl. Acad. Sci. USA 94:5417-5421.
Gardner, B. (1995). Trends Pharmacol. Sci. 16:259-260.
Hashido, K., Adachi, M., Gamou, T., Watanabe, T., Furuichi, Y., and Miyamoto, C. (1993). Cell. Mol. Biol. Res. 39:3-12.
Hescheler, J., and Schultz, G. (1993). Curr. Opin. Neurobiol. 3:360-367.
Hilal-Dandan, R., Ramirez, M. T., Villegas, S., Gozalez, A., Endo-Mochizuki, Y., Brown, J. H., and Brunton, L. L. (1997). Am. J. Physiol. 272:H130-H137.
Hu, S., Kim, H. S., and Jeng, A. Y. (1991). Eur. J. Pharmacol. 194:31-36.
Hunt, T. W., Carroll, R. C., and Peralta, E. G. (1994). J. Biol. Chem. 269:29565-29570.
Jones, G. L. (1996). Life Sci. 58:115-123.
Kanyicska, B., Freeman, M. E., and Dryer, S. E. (1997). Endocrinology 138:3141-3153.
Kasuya, Y., Abe, Y., Hama, H., Sakurai, T., Asada, S., Masaki, T., and Goto, K. (1994). Biochem. Biophys. Res. Commun. 204:1325-1333.
Kenakin, T. (1995). Trends Pharmacol. Sci. 16:232-238.
Koizumi, S., Kataoka, Y., Niwa, M., Yamashita, K., Taniyama, K., and Kudo, Y. (1994). Neurosci. Rep. 5:1077-1080.
Kruger, H., Carr, S., Brennand, J. C., and McLean, J. S. (1995). Biochem. Biophys. Res. Commun. 217:52-58.
Laugwitz, K.-L., Allgeier, A., Offermanns, S., Spicher, K., Van Sande, J., Dumont, J. E., and Schultz, G. (1996). Proc. Natl. Acad. Sci. USA 93:116-120.
Lee, J. A., Brinkmann, J. A., Longton, E. D., Peishoff, C. E., Lago, M. A., Leber, J. D., Cousins, R. D., Gao, A., Stadel, J. M., Kumar, C. S., Ohlstein, E. H., Gleason, J. G., and Elliot, J. D. (1994). Biochemistry 33:14543-14549.
Leff, P., Scaramellini, C., Law, C., and McKechnie, K. (1997). Trends Pharmacol. Sci. 18: 355-362.
Liu, W. W., Mattingly, R. R., and Garrison, J. C. (1996). Proc. Natl., Acad. Sci. USA 93:8258-8263.
Milligan, G. (1993). Trends Pharmacol. Sci. 14:239-244.
Minami, K., Hirata, Y., Tokumura, A., Nakaya, Y., and Fukuzawa, K. (1995). Biochem. Pharmacol. 49:1051-1056.
Sakamoto, A., Yanagisawa, M., Sawamura, T., Enoki, T., Ohtani, T., Sakurai, T., Nakao, K., Toyo-Oka, T., and Masaki, T. (1993). J. Biol. Chem. 268:8547-8553.
Selbie, L. A., and Hill, S. J. (1998). Trends Pharmacol. Sci. 19:87-93.
Shraga-Levine, Z., and Sokolovsky, M. (1996a). Circ. Res. 78:424-430.
Shraga-Levine, Z., and Sokolovsky, M. (1996b). Eur. J. Neurosci. Suppl. 9:61.
Shraga-Levine, Z., Galron, R., and Sokolovsky, M. (1994). Biochemistry 33:14656-14659.
Sokolovsky, M. (1993). Cell. Signal. 5:473-483.
Sokolovsky, M. (1995). Pharmacol. Ther. 68:435-471.
Sokolovsky, M., Shraga-Levine, Z., and Galron, R. (1994). Biochemistry 33:11417-11419.
Strange, P. G. (1998). Trends Pharmacol. Sci. 19:85-86.
Takagi, Y., Ninomiya, H., Sakamoto, A., Miwa, S., and Masaki, T. (1995). J. Biol. Chem. 270:10072-10078.
Tucek, S. (1997). Trends Pharmacol. Sci. 18:414-416.
Vigne, P., Ladoux, A., and Frelin, C. (1991). J. Biol. Chem. 266:5925-5928.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shraga-Levine, Z., Sokolovsky, M. Functional Coupling of G Proteins to Endothelin Receptors Is Ligand and Receptor Subtype Specific. Cell Mol Neurobiol 20, 305–317 (2000). https://doi.org/10.1023/A:1007010125316
Issue Date:
DOI: https://doi.org/10.1023/A:1007010125316